March 30, 2026
We’re proud to share that as of March 1st, dr. Ingrid de Visser-Kamerling has officially stepped into the role of Chief Operating Officer at…
An important step forward in the fight against antimicrobial resistance (AMR). As antibiotics are losing effectiveness worldwide, bacteriophages are increasingly seen as a promising…
December 2, 2025
November 26, 2025
Today our COO Ingrid de Visser-Kamerling was live on the BNR Nieuwsradio with Koenraad Wiedhaup to talk about the recent developments in infectious disease…
Clostridioides difficile (C. difficile) remains a major cause of healthcare-associated diarrhoea, with rising antibiotic resistance and frequent relapses making treatment…
In this study schistosomiasis research is boosted by developing the first controlled human infection model using female-only Schistosoma mansoni parasites….
Despite decades of effort, malaria remains a global health challenge, with current vaccines offering only modest and short-lived protection. This…
Hookworm remains a persistent health threat in many parts of the world, with reinfection common despite mass drug treatments. This…
July 7, 2025
July 5, 2025
July 4, 2025
July 3, 2025
Let us know:
